Clinical Trial Update: Results of Mass Switch From Latanoprost to Travoprost

View source ↗

Summary

The trial reports the results of a mass switch from latanoprost to travoprost in patients with glaucoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Glaucoma | Status: COMPLETED